1. Home
  2. NLSP vs HAO Comparison

NLSP vs HAO Comparison

Compare NLSP & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • HAO
  • Stock Information
  • Founded
  • NLSP 2015
  • HAO 2018
  • Country
  • NLSP Switzerland
  • HAO China
  • Employees
  • NLSP N/A
  • HAO N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • HAO
  • Sector
  • NLSP Health Care
  • HAO
  • Exchange
  • NLSP Nasdaq
  • HAO NYSE
  • Market Cap
  • NLSP 12.4M
  • HAO 4.2M
  • IPO Year
  • NLSP 2021
  • HAO 2024
  • Fundamental
  • Price
  • NLSP $2.10
  • HAO $1.36
  • Analyst Decision
  • NLSP
  • HAO
  • Analyst Count
  • NLSP 0
  • HAO 0
  • Target Price
  • NLSP N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • NLSP 269.6K
  • HAO 28.0K
  • Earning Date
  • NLSP 07-22-2025
  • HAO 07-18-2025
  • Dividend Yield
  • NLSP N/A
  • HAO N/A
  • EPS Growth
  • NLSP N/A
  • HAO N/A
  • EPS
  • NLSP N/A
  • HAO 0.19
  • Revenue
  • NLSP N/A
  • HAO $48,970,924.00
  • Revenue This Year
  • NLSP N/A
  • HAO N/A
  • Revenue Next Year
  • NLSP N/A
  • HAO N/A
  • P/E Ratio
  • NLSP N/A
  • HAO $7.01
  • Revenue Growth
  • NLSP N/A
  • HAO 15.04
  • 52 Week Low
  • NLSP $1.30
  • HAO $0.84
  • 52 Week High
  • NLSP $15.59
  • HAO $172.73
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 46.61
  • HAO 51.84
  • Support Level
  • NLSP $2.20
  • HAO $1.29
  • Resistance Level
  • NLSP $3.08
  • HAO $1.41
  • Average True Range (ATR)
  • NLSP 0.25
  • HAO 0.10
  • MACD
  • NLSP -0.06
  • HAO 0.01
  • Stochastic Oscillator
  • NLSP 8.40
  • HAO 66.31

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: